Published mark
AVITA Medical, Inc.
OTC: AVHHL. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:b79e4702-7627-434b-9fef-001b81e6c01e
- SEC CIK
- 0001762303
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 22, 2026
- Newest evidence
- Apr 22, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Cary VanceSince Feb 12, 2026
- Chair
- Not published
- Independent
- Not published6 directors published
- Published claims
- 293 distinct sources
- Evidence records
- 60 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
CDI Holders seat on AVITA Medical, Inc., effective 2026-04-22.
EffectiveEffective Apr 22, 2026E2
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Interim Chief Executive Officer | Cary Vance | Feb 2026 | current | Source reportedE3 |
| Chief Financial Officer | David O'Toole | Feb 2026 | current | Source reportedE4 |
| Chief Legal and Compliance Officer and Corporate Secretary; Interim SVP, HR | Nicole Kelsey | Feb 2026 | current | Source reportedE5 |
Board of directors
Evidence6 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Cary Vance | Independence not published | 2023 | None published | Source reportedE2 |
| CDI Holders | Independence not published | 2026 | None published | Source reportedE2 |
| Jan Stern Reed | Independence not published | 2021 | Audit CommitteeHuman Capital and Compensation CommitteeNominating and Corporate Governance Committee, chair | Source reportedE2 |
| Jeremy Curnock Cook | Independence not published | 2012 | Audit CommitteeHuman Capital and Compensation CommitteeNominating and Corporate Governance Committee | Source reportedE2 |
| Joseph Woody | Independence not published | 2026 | Audit CommitteeHuman Capital and Compensation CommitteeNominating and Corporate Governance Committee | Source reportedE2 |
| Robert McNamara | Independence not published | 2023 | Audit Committee, chairHuman Capital and Compensation CommitteeNominating and Corporate Governance Committee | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit Committee | Robert McNamara | Robert McNamara, Jan Stern Reed, Jeremy Curnock Cook, Joseph Woody | Not described in the published record |
| Human Capital and Compensation Committee | Not published | Jan Stern Reed, Jeremy Curnock Cook, Joseph Woody, Robert McNamara | human_capital, financial |
| Nominating and Corporate Governance Committee | Jan Stern Reed | Jan Stern Reed, Jeremy Curnock Cook, Joseph Woody, Robert McNamara | Not described in the published record |
Committee RecordAudit Committee: Chair Robert McNamara; Members Robert McNamara (Chair); Jan Stern Reed; Jeremy Curnock Cook; Joseph Woody
Committee AppointmentRobert McNamara: chair, Audit Committee
Committee AppointmentJan Stern Reed: member, Audit Committee
Committee AppointmentJeremy Curnock Cook: member, Audit Committee
Committee AppointmentJoseph Woody: member, Audit Committee
Committee RecordHuman Capital and Compensation Committee: Chair Dr. Michael Tarnoff; Members Jan Stern Reed; Jeremy Curnock Cook; Joseph Woody; Robert McNamara
Committee AppointmentJan Stern Reed: member, Human Capital and Compensation Committee
Committee AppointmentJeremy Curnock Cook: member, Human Capital and Compensation Committee
Committee AppointmentJoseph Woody: member, Human Capital and Compensation Committee
Committee AppointmentRobert McNamara: member, Human Capital and Compensation Committee
Committee RecordNominating and Corporate Governance Committee: Chair Jan Stern Reed; Members Jan Stern Reed (Chair); Jeremy Curnock Cook; Joseph Woody; Robert McNamara
Committee AppointmentJan Stern Reed: chair, Nominating and Corporate Governance Committee
Committee AppointmentJeremy Curnock Cook: member, Nominating and Corporate Governance Committee
Committee AppointmentJoseph Woody: member, Nominating and Corporate Governance Committee
Committee AppointmentRobert McNamara: member, Nominating and Corporate Governance Committee
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerCary Vance, Interim Chief Executive Officer, from Feb 12, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingAVHHL (OTC)
Security ListingRCEL (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 23, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameAVITA Medical, Inc.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Cary VanceInterim Chief Executive Officer; Directorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:11, company:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:5
- David O'TooleChief Financial Officercompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:12
- Nicole KelseyChief Legal and Compliance Officer and Corporate Secretary; Interim SVP, HRcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:13
- CDI HoldersDirectorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:6
- Jan Stern ReedDirectorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:7
- Jeremy Curnock CookDirectorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:8
- Joseph WoodyDirectorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:9
- Robert McNamaraDirectorcompany:b79e4702-7627-434b-9fef-001b81e6c01e:leadership_role:10
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 6 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 22, 2026. Cited by 5 Claims.
- E2sec proxy. Published Apr 22, 2026. Retrieved Sep 2, 2026. Cited by 6 Claims.
- E3sec filing. Published Feb 12, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E4sec filing. Published Feb 12, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E5sec filing. Published Feb 12, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E6governance_people_committees. sec proxy. Cited by 15 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 22, 2026- CDI Holders seat on AVITA Medical, Inc., effective 2026-04-22.
- Cary Vance executive of AVITA Medical, Inc., effective 2026-02-12.
- David O'Toole executive of AVITA Medical, Inc., effective 2026-02-12.
- Nicole Kelsey executive of AVITA Medical, Inc., effective 2026-02-12.
- Joseph Woody seat on AVITA Medical, Inc., effective 2026-01-01.
- Cary Vance seat on AVITA Medical, Inc., effective 2023-01-01.
- Robert McNamara seat on AVITA Medical, Inc., effective 2023-01-01.
- Jan Stern Reed seat on AVITA Medical, Inc., effective 2021-01-01.
- Jeremy Curnock Cook seat on AVITA Medical, Inc., effective 2012-01-01.